MPLTMapLight Therapeutics, Inc.

$12.92

Who owns MPLT

81 institutions reported holding MPLT for 2026Q1, together 55% of the company, more than the 74 a quarter earlier.

81

Institutions reporting a position · as of 2026Q1 · up from 74 the quarter before

Shares held by institutions
24.7M

Shares held by institutions · 55% of the company · long US equity positions only, as reported on Form 13F

Reported value
$502M

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
29%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
2
New positions
18
Positions exited
14
Added to
26
Reduced
12
Top 10 holdersof the company
39%
Largest reported holders, 2026Q1
HolderShares% of companyValue
NOVO HOLDINGS A/S3.7M8.1%$75M
FCPM III SERVICES B.V.3.2M7.1%$66M
T. Rowe Price Investment Management, Inc.2.8M6.2%$57M
GOLDMAN SACHS GROUP INC2.0M4.4%$41M
BlackRock Inc.1.3M3.0%$27M
Blue Owl Capital Holdings LP1.0M2.2%$20M
VANGUARD GROUP INC1.0M2.1%$20M
Nan Fung Group Holdings Ltd1.0M2.1%$20M
5AM Venture Management, LLC1.0M2.1%$19M
Sanofi0.9M2.0%$19M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…